Outcome after redo coronary artery bypass grafting in patients with ischaemic cardiomyopathy and viable myocardium

Heart

Volumn 93, Issue 2, 2007, Pages 221-225

  Rizzello, V ^a   Poldermans, D ^a   Schinkel, A F L ^a   Biagini, E ^a   Boersma, E ^a   Elhendy, A ^a   Sozzi, F B ^a   Palazzuoli, A ^a   Maat, A ^a   Crea, F ^b   Bax, J J ^c  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b CATHOLIC UNIVERSITY   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE;

ADULT; ARTICLE; CARDIOMYOPATHY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; FEMALE; FOLLOW UP; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART MUSCLE REVASCULARIZATION; HUMAN; MALE; PRIORITY JOURNAL; STRESS ECHOCARDIOGRAPHY; SURGICAL MORTALITY; TREATMENT OUTCOME;

AGED; CARDIOTONIC AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY BYPASS; DISEASE PROGRESSION; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RECURRENCE; REOPERATION; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 33846633714     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2006.088146     Document Type: Article

References (23)

1. Roger VL, Weston SA, Redfield MM, et al. Trends in heart failure incidence and survival in a community-based population. JAMA 2004;292:344-50.
2. Bax JJ, Poldermans D, Elhendy A, et al. Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. J Am Coll Cardiol 1999;34:163-9.
3. Ragosta M, Beller GA, Watson DD, et al. Quantitative planar rest-redistribution 201T1 imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87:1630-41.
4. Vanoverschelde JL, Gerber BL, D'Hondt AM, et al. Preoperative selection of patients with severely impaired left ventricular function for coronary revascularization. Role or low-dose dobutamine echocardiography and exercise-redistribution-reinjection thallium SPECT. Circulation 1995;92(Suppl):1137-44.
5. Pagano D, Bonser RS, Townend JN, et al. Predictive value of dobutamine echocardiography and positron emission tomography in identifying hibernating myocardium in patients with postischaemic heart failure. Heart 1998;79:281-8.
6. Di Carli MF, Asgarzadie F, Schelbert HR, et al. Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. Circulation 1995;92:3436-44.
7. Pagley PR, Beller GA, Watson DD, et al. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997;96:793-800.
8. Meluzin J, Cerny J, Frelich M, et al. Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. Investigators of this Multicenter Study. J Am Coll Cardiol 1998;32:912-20.
9. Lee KS, Marwick TH, Cook SA, et al. Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization. Circulation 1994;90:2687-94.
10. Weintraub WS, Jones EL, Craver JM, et al. In-hospital and long-term outcome after reoperative coronary artery bypass graft surgery. Circulation 1995;92(Suppl):II50-7.
11. Van Eck FM, Noyez L, Verheugt FW, et al. Analysis of mortality within the first six months after coronary reoperation. Ann Thorac Surg 2002;74:2106-12.
12. Noyez L, van Eck FM. Long-term cardiac survival after reoperative coronary artery bypass grafting. Eur J Cardiothorac Surg 2004;25:59-64.
13. Shapira I, Isakov A, Heller I, et al. Long-term follow-up after coronary artery bypass grafting reoperation. Chest 1999;115:1593-7.
14. Di Mauro M, Iaco AL, Contini M, et al. Reoperative coronary artery bypass grafting: analysis of early and late outcomes. Ann Thorac Surg 2005;79:81-7.
15. Allman KC, Shaw U, Hachamovitch R, et al. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-8.
16. Schiller NB, Shah PM, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989;2:358-67.
17. Salustri A, Ciavatti M, Seccareccia F, et al. Prediction of cardiac events after uncomplicated acute myocardial infarction by clinical variables and dobutamine stress test. J Am Coll Cardiol 1999;34:435-40.
18. Arnese M, Cornel JH, Salustri A, et al. Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocordiograpny with 201T1 single-photon emission computed tomography. Circulation 1995;91:2748-52.
19. Afridi I, Kleiman NS, Raizner AE, et al. Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty. Circulation 1995;91:663-70.
20. Rizzello V, Bax JJ, Poldermans D. Assessment of myocardial viability in chronic ischemic heart disease: current status. Q J Nucl Med Mol Imaging 2005;49:81-96.
21. He GW, Acuff TE, Ryan WH, et al. Determinants of operative mortality in reoperative coronary artery bypass grafting. J Thorac Cardiovasc Surg 1995;110:971-8.
22. Gheorghiade M, Bonow RO. Chronic heart failure in the United States: a manifestation of coronary artery disease. Circulation 1998;97:282-9.
23. Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1693-700.